ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Hematologic Cancer
Lymphoma
Cancer
Leukemia
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Los Angeles, CA, USA:

Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.

This is a pilot study evaluating the safety and efficacy of selinexor among multiple myeloma (MM) patients that are refractory to l...

Enrolling
Refractory Multiple Myeloma
Drug: Selinexor
Drug: Lenalidomide

Phase 1

Oncotherapeutics

West Hollywood, California, United States of America

This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...

Enrolling
Multiple Myeloma
Drug: Ruxolitinib Oral Tablet [Jakafi]
Drug: Methylprednisolone

Phase 1

Oncotherapeutics

West Hollywood, California, United States and 12 other locations

a phase 1b, open-label, dose-escalation study of STI-1492 administered by a single intravenous infusion in subjects with relapsed or refractory multiple...

Enrolling
Multiple Myeloma
Biological: STI-1492

Phase 1

Sorrento Therapeutics
Sorrento Therapeutics

Orange, California, United States and 2 other locations

This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...

Active, not recruiting
Multiple Myeloma
Myeloma
Drug: Cyclophosphamide
Drug: Bendamustine

Phase 1

Fate Therapeutics
Fate Therapeutics

Duarte, California, United States and 13 other locations

The purpose of this study is to evaluate the safety and preliminary efficacy of CC-95266 in participants with relapsed and/or refractory multiple...

Active, not recruiting
Multiple Myeloma
Drug: Bendamustine
Drug: CC-95266

Phase 1

Juno Therapeutics

Duarte, California, United States and 9 other locations

The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...

Active, not recruiting
Multiple Myeloma
Biological: Ixazomib
Drug: Dexamethasone

Phase 2

The Washington University
The Washington University

Duarte, California, United States and 9 other locations

versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...

Active, not recruiting
Multiple Myeloma
Biological: bb2121
Drug: Dexamethasone

Phase 3

Celgene
Celgene

Los Angeles, California, United States and 59 other locations

phases, for the treatment of patients with relapsed/refractory multiple myeloma (RRMM) and newly diagnosed multiple myeloma...

Enrolling
Multiple Myeloma
Drug: Selinexor
Drug: Mezigdomide

Phase 1, Phase 2

Karyopharm Therapeutics
Karyopharm Therapeutics

Los Angeles, California, United States and 24 other locations

Locations recently updated

of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, i...

Enrolling
Multiple Myeloma
Drug: Fludarabine
Drug: Cyclophosphamide

Phase 3

Gilead Sciences
Gilead Sciences

Santa Monica, California, United States and 6 other locations

This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical ben...

Enrolling
Multiple Myeloma
Drug: Elranatamab

Phase 4

Pfizer
Pfizer

Orange, California, United States and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems